Literature DB >> 18843901

Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patients.

Nicola Gianotti1, Myriam Maillard, Giovanni Gaiera, Arabella Bestetti, Massimo Cernuschi, Anna De Bona, Adriano Lazzarin, Paola Cinque, Simona Bossolasco.   

Abstract

An HIV-infected patient started combination antiretroviral therapy with 13 CD4+ cells/microL. Despite sustained virological suppression over the following four years, the anemia did not resolve, and the CD4+ cell counts always remained below 200/microL until co-infection with Leishmania was diagnosed in October 2006 when the patient started complaining of persistent mild fever and asthenia. Once treatment for leishmaniasis was started with miltefosine, CD4+ cell count rose above 400/microL. A new drop in CD4+ cell count was observed when Leishmania DNA turned out again to be positive, but treatment with liposomal amphotericin-B restored immune recovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843901

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  1 in total

1.  Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells?

Authors:  Rafael Van den Bergh; Jo A Van Ginderachter; Elio Schouppe; Belete A Desimmie; Asrat Hailu; Patrick De Baetselier; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.